View Document Preview and Link Document Date: 2012-03-07 21:04:50 Open Document File Size: 902,34 KB Share Result on Facebook
City Barcelona / Heilbronn / / Company Mitsubishi / Takeda Pharmaceuticals / Aventis / GMP (Good Manufacturing Practice) Pharma / Amgen / Greenovation 7 8 1 Pharmaceutical Biotechnology / EPO / Genentech / Wiley-VCH Verlag GmbH & Co. KGaA / Eisai / Protalix / Schering / Wyeth / Novo Nordisk / / Continent Europe / / Country Germany / United States / / Currency USD / / Event FDA Phase / / Facility J. Craig Venter Institute / Washington University / / IndustryTerm biotech drug products / gene technology / monoclonal antibody-based products / biological devices / non-invasive delivery systems / undesirable biopharmaceutical hurdles / biotechnology / biotechnology level / mammalian production systems / pharmaceutical and chemical engineering / gene delivery systems / pharmaceutical laboratories / drug manufacturing process / biological systems / platform technology / downstream processing / host systems / pharmaceutical technology / public healthcare reforms / manufacturing process / pharmaceutical applications / media optimization / plant systems / recombinant therapeutic products / recombinant biotechnology / treatment of cancer / enzyme-based processing step / therapy of neoplastic diseases / classical recombinant biotechnology / chemical / erythropoietin-based products / System biotechnology / biotechnology sector / secondary natural products / pharmaceutical biotechnology / / MedicalCondition arthritis / heart disease / blood clots / multiple sclerosis / Familial Cold Auto-inflammatory Syndrome / II diabetes / cancers / autoimmune disorders / Muckle-Wells Syndrome / Alzheimer’s disease / cancer / neoplastic diseases / diabetes / kbp Hepatitis C / diseases / non-Hodgkin lymphoma / AIDS / HIV/AIDS / / MedicalTreatment renal transplants / organ transplants / vaccinations / somatic gene therapy / / Organization LaMerie Business Intelligence / Food and Drug Administration / SUNY / European Medicines Agency / FDA / Washington University / J. Craig Venter Institute / / Person Oliver Kayser / / Position high producer / / Product Humira / Mircera / Herceptin / Zenapax / Rituxan / Cerezyme / Aranesp / Polyethylene glycol / Soliris / Macugen / Lantus / Valtropin / Neulasta / Oncaspar / Remicade / Exubera / PEGintron / Accretropin / Recombinant Drug / Avastin / Lucentis / xylose / Increlex / Eprex / Orencia / Vectibix / Somavert / Enbrel / Novolog mix / ReoPro / Retavase / Pegasys / Myozyme / glycine / Naglazyme / Arcalyst / Tysabri / Omnitrope / Elaprase / / Technology alpha / protein engineering / bioinformatics / antibodies / Biotechnology / directed mutagenesis / gene therapy / drug delivery / biopharmaceuticals / Drug Discovery / Key enabling technologies / phage display / genetic code / platform technology / DNA sequencing / gene delivery / pharmacodynamics / gene technology / Business Intelligence / drug development / / SocialTag 
1 Part One Concepts and Methods for Recombinant Drug Production 3